Report Detail

Other Global and China Cancer mTOR Inhibitors Market Research by Company, Type & Application 2013-2025

  • RnM2140072
  • |
  • 01 June, 2018
  • |
  • Global
  • |
  • 105 Pages
  • |
  • HeyReport
  • |
  • Other

Table of Contents

    1 Market Overview

    • 1.1 Market Segment Overview
      • 1.1.1 Product Definition
      • 1.1.2 Market by Type
        • 1.1.2.1 Afinitor/Votubia
        • 1.1.2.2 Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor
        • 1.1.2.3 Torisel (Temsirolimus)
        • 1.1.2.4 Evertor andndash
      • 1.1.3 Market by Application
        • 1.1.3.1 Breast Cancer
        • 1.1.3.2 Hematological Malignancy
        • 1.1.3.3 Neuroendocrine Tumors
        • 1.1.3.4 Hepatocellular Carcinoma
        • 1.1.3.5 Glioblastoma
    • 1.2 Global and Regional Market Size
      • 1.2.1 Global Overview
      • 1.2.2 China Overview

    2 Global and Regional Market by Company

    • 2.1 Global
      • 2.1.1 Global Sales by Company
      • 2.1.2 Global Price by Company
    • 2.2 China
      • 2.2.1 China Sales by Company
      • 2.2.2 China Price by Company

    3 Global and Regional Market by Type

    • 3.1 Global
      • 3.1.1 Global Sales by Type
      • 3.1.2 Global Price by Type
    • 3.2 China
      • 3.2.1 China Sales by Type
      • 3.2.2 China Price by Type

    4 Global and Regional Market by Application

    • 4.1 Global
      • 4.1.1 Global Sales by Application
      • 4.1.2 Global Price by Application
    • 4.2 China
      • 4.2.1 China Sales by Application
      • 4.2.2 China Price by Application

    5 Regional Trade

    • 5.1 Export
    • 5.2 Import

    6 Key Manufacturers

    • 6.1 Abraxis BioScience
      • 6.1.2 Company Information
      • 6.1.2 Product Specifications
      • 6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.2 Adimab
      • 6.2.1 Company Information
      • 6.2.2 Product Specifications
      • 6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.3 Celgene Corporation
      • 6.3.1 Company Information
      • 6.3.2 Product Specifications
      • 6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.4 Celator Pharmaceuticals
      • 6.4.1 Company Information
      • 6.4.2 Product Specifications
      • 6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.5 Eli Lilly
      • 6.5.1 Company Information
      • 6.5.2 Product Specifications
      • 6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.6 Exelixis
      • 6.6.1 Company Information
      • 6.6.2 Product Specifications
      • 6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.7 GlaxoSmithKline
      • 6.7.1 Company Information
      • 6.7.2 Product Specifications
      • 6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.8 HEC Pharm
      • 6.8.1 Company Information
      • 6.8.2 Product Specifications
      • 6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.9 Intellikine
      • 6.9.1 Company Information
      • 6.9.2 Product Specifications
      • 6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.10 Novartis
      • 6.10.1 Company Information
      • 6.10.2 Product Specifications
      • 6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.11 Oneness Biotech
    • 6.12 PIQUR Therapeutics
    • 6.13 Semafore Pharmaceuticals
    • 6.14 Takeda
    • 6.15 Wyeth

    7 Industry Upstream

    • 7.1 Industry Chain
    • 7.2 Raw Materials

    8 Market Environment

    • 8.1 SWOT
    • 8.2 Porter's Five Forces

    9 Conclusion

    Summary
    Market Segment as follows:
    By Type
    Afinitor/Votubia
    Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor
    Torisel (Temsirolimus)
    Evertor andndash
    By Application
    Breast Cancer
    Hematological Malignancy
    Neuroendocrine Tumors
    Hepatocellular Carcinoma
    Glioblastoma
    By Company
    Abraxis BioScience
    Adimab
    Celgene Corporation
    Celator Pharmaceuticals
    Eli Lilly
    Exelixis
    GlaxoSmithKline
    HEC Pharm
    Intellikine
    Novartis
    Oneness Biotech
    PIQUR Therapeutics
    Semafore Pharmaceuticals
    Takeda
    Wyeth
    The main contents of the report including:
    Section 1:
    Product definition, type and application, global and China market overview;
    Section 2:
    Global and China Market competition by company;
    Section 3:
    Global and China sales revenue, volume and price by type;
    Section 4:
    Global and China sales revenue, volume and price by application;
    Section 5:
    China export and import;
    Section 6:
    Company information, business overview, sales data and product specifications;
    Section 7:
    Industry chain and raw materials;
    Section 8:
    SWOT and Porter's Five Forces;
    Section 9:
    Conclusion.


    Summary:
    Get latest Market Research Reports on Cancer mTOR Inhibitors. Industry analysis & Market Report on Cancer mTOR Inhibitors is a syndicated market report, published as Global and China Cancer mTOR Inhibitors Market Research by Company, Type & Application 2013-2025. It is complete Research Study and Industry Analysis of Cancer mTOR Inhibitors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,000.00
    $3,000.00
    $4,000.00
    1,456.00
    2,184.00
    2,912.00
    1,722.00
    2,583.00
    3,444.00
    228,300.00
    342,450.00
    456,600.00
    150,120.00
    225,180.00
    300,240.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report